Rajeev M. Shah, Director, 10% Owner at Werewolf Therapeutics, Inc. (HOWL), bought 1,853,000 shares at $2.21 ($4.1M) on 2023-01-06, disclosed to the SEC on 2023-01-10.
Open-market purchase of $4.1M HOWL by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| SEPN | BUY | 2024-10-30 | $75.1M | — | Filing → |
| AVTE | BUY | 2024-06-20 | $3.1M | — | Filing → |
| IMRA | BUY | 2022-12-12 | $191K | — | Filing → |